Open access
49
Views
0
CrossRef citations to date
0
Altmetric
Commentary
The use of remdesivir outside of clinical trials during the COVID-19 pandemic
Vesa Halimi1 Faculty of Pharmacy,University Ss. Cyril and Methodius University,Skopje,North Macedonia.
, Armond Daci2 Department of Pharmacy, Faculty of Medicine,University of Prishtina,Prishtina,Kosovo.
, Nevenka Ridova3 University Clinic of Hematology, Medical Faculty,University Ss. Cyril and Methodius University,Skopje,North Macedonia.
, Irina Panovska-Stavridis3 University Clinic of Hematology, Medical Faculty,University Ss. Cyril and Methodius University,Skopje,North Macedonia.
, Milena Stevanovic4 University Clinic of Infection Diseases and Febrile Conditions, Medical Faculty,University Ss. Cyril and Methodius,Skopje,North Macedonia.
, Venko Filipce5 University Clinic for Neurosurgery, Medical Faculty,University Ss. Cyril and Methodius,Skopje,North Macedonia.
, Aleksandar Dimovski1 Faculty of Pharmacy,University Ss. Cyril and Methodius University,Skopje,North Macedonia.
& Aleksandra Grozdanova1 Faculty of Pharmacy,University Ss. Cyril and Methodius University,Skopje,North Macedonia.Correspondence[email protected]
https://orcid.org/0000-0002-0098-8691
Article: 61
|
Received 03 Jul 2020, Accepted 18 Aug 2020, Published online: 04 Dec 2023
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.